Category Archives: Dr. Lucey COVID-19 Origins

Will the China report on 266 patients Nov. 17-Dec. 31, 2019 be made public by China, WHO, or by WHA resolution next week?

By on .

By Daniel R. Lucey MD, MPH, FIDSA In a recent Science paper by Pekar, Worobey and colleagues titled “Timing the SARS-CoV-2 index case in Hubei province” the authors conclude “Our results define the period between mid-October and mid-November 2019 as the plausible interval when the first case of SARS-CoV-2 emerged in Hubei province.” Referencing reporting […]

Four problems with the lab origin hypothesis of SARS-CoV-2 and the WHO-China study

By on .

By Daniel R. Lucey MD, MPH, FIDSA Today the Joint WHO-China Study 14 January-10 February 2021 for the “WHO-convened Global Study of origins of SARS-CoV-2: China Part” was posted on the World Health Organization’s website.  Zero patients with COVID were reported before December 8, 2021, yet 174 patients were found between Dec. 8 to 31, […]

Will the next “WHO-convened Global Study of the origins of SARS-CoV-2” be in SE Asia, Europe, or the Americas?

By on .

By Daniel R. Lucey MD, MPH, FIDSA By July 31, 2020 the World Health Organization and China had agreed in writing to a highly-consequential document with long-term implications titled “WHO-convened Global Study of the Origins of SARS-CoV-2: Terms of References for the China Part”. This title, as well as multiple statements in the text such […]

Why did the WHO-China team call the lab origin hypothesis “extremely unlikely” when their “Terms of References” did not mention it at all?

By on .

By Daniel R. Lucey MD, MPH, FIDSA Following the May 2020 World Health Assembly resolution 73.1 regarding COVID-19 (item 6 on page 6), the World Health Organization and China agreed in writing in a July 31 July 2020 document titled “WHO-convened Global Study of the Origins of SARS-CoV-2 ‘Terms of References for the China Part‘”. […]

FDA-USDA statement timely in light of imminent WHO-China COVID-19 team summary

By on .

By Daniel R. Lucey MD, MPH, FIDSA Today this statement (also provided below) from the United States Food and Drug Administration, acting Commissioner Janet Woodcock M.D., and US Department of Agriculture acting Secretary Kevin Shea concluded that there is currently no scientific or epidemiologic basis for the claim that SARS-CoV-2/COVID-19 is transmitted via food or […]

Advances since 2001 include FDA-approved anthrax antitoxins available now

By on .

With most eyes on COVID-19, it would be prudent to remain vigilant for older threats at the same time By Daniel R. Lucey MD, MPH, FIDSA A major difference in treatment and prophylaxis for inhalational anthrax since the attacks of 2001 is the availability of three U.S. Food and Drug Administration approved antitoxins. Several key […]

Five questions on new data from China-WHO showing 124 confirmed coronavirus patients in December 2019

By on .

By Daniel R. Lucey M.D., MPH, FIDSA After China initially reported 41, then ~ 46, and then ~ 100 laboratory-confirmed cases in December 2019, a total of 124 confirmed cases in December was reported by China July 31 but for some reason only posted on the WHO website Nov. 5. First posted on the WHO […]

COVID-19: WHO-China team “Terms of Reference” reveal new data on seafood market

By on .

By Daniel R. Lucey M.D., MPH, FIDSA On Nov. 5, the World Health Organization posted on its website an important nine-page document titled: “WHO-Convened Global Study of the Origins of SARS-CoV2: Terms of Reference for the China Part.” This document is important for many reasons.  First, it is dated 31 July 2020 (upper left under […]

COVID-19: Eight key factual statements from Wuhan Institute of Virology’s Dr. Zhengli Shi

By on .

By Daniel R. Lucey M.D., MPH, FIDSA In response to a series of questions asked by Science magazine’s Jon Cohen, the Wuhan Institute of Virology’s internationally-renowned bat coronavirus researcher and collaborator (with scientists in the United States, Singapore, and elsewhere), Dr. Zhengli Shi provided key facts about her work. Among questions she addressed were ones […]

COVID-19: Eight questions for the WHO team going to China next week to investigate pandemic origins

By on .

By Daniel R. Lucey M.D., MPH, FIDSA Today the South China Morning Post reported that on Monday the World Health Organization Director General Tedros Adhanom Gehbreysus stated “We can fight the virus better when we know everything about the virus, including how it started . . .We will be sending a team next week to […]